Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
TERMINATED
NCT05492851
PHASE4

Trial Comparing Three Single Dose Injections for Knee Osteoarthritis

Sponsor: Ohio State University

View on ClinicalTrials.gov

Summary

This study is a 3-arm, double-blind, randomized trial comparing the clinical outcomes of Zilretta, Synvisc One, and Monovisc for knee OA.

Official title: A Double-blind, Randomized Trial Comparing Three Single Dose Injections for Knee Osteoarthritis

Key Details

Gender

All

Age Range

25 Years - 85 Years

Study Type

INTERVENTIONAL

Enrollment

6

Start Date

2022-08-02

Completion Date

2023-01-11

Last Updated

2026-09-17

Healthy Volunteers

No

Interventions

DRUG

Zilretta

Intra-articular injection to treat knee osteoarthritis

DRUG

Synvisc-One 48 MG in 6 ML Prefilled Syringe

Intra-articular injection to treat knee osteoarthritis

DRUG

Monovisc 88 MG Per 4 ML Prefilled Syringe

Intra-articular injection to treat knee osteoarthritis

Locations (2)

Jameson Crane Sports Medicine Institute

Columbus, Ohio, United States

Ohio State Outpatient Lewis Center

Lewis Center, Ohio, United States